Nancy Lurker insider trades
Open-market stock purchases and sales by Nancy Lurker, Director at Alkermes plc., from SEC Form 4 filings since Mar 1, 2010.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +73%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 21, 2026 | ALKS Alkermes plc. | Sold (not open market) | $54.5K |
| May 21, 2026 | ALKS Alkermes plc. | Bought (not open market) | — |
| May 20, 2026 | ALKS Alkermes plc. | Bought (not open market) | — |
| May 20, 2026 | ALKS Alkermes plc. | Bought (not open market) | — |
| May 14, 2026 | COLL Collegium Pharmaceutical, Inc | Bought (not open market) | — |
| May 13, 2026 | COLL Collegium Pharmaceutical, Inc | Sold | $162K |
| Apr 11, 2026 | ALKS Alkermes plc. | Sold (not open market) | $30.1K |
| Apr 11, 2026 | ALKS Alkermes plc. | Bought (not open market) | — |
| Jan 6, 2026 | EYPT EyePoint, Inc | Bought (not open market) | — |
| Jan 5, 2026 | EYPT EyePoint, Inc | Bought (not open market) | — |
| Jan 2, 2026 | EYPT EyePoint, Inc | Bought (not open market) | — |
| Dec 4, 2025 | EYPT EyePoint Pharmaceuticals, Inc | Sold | $140K |
| Nov 28, 2025 | EYPT EyePoint Pharmaceuticals, Inc | Sold | $7.5K |
| Nov 26, 2025 | EYPT EyePoint Pharmaceuticals, Inc | Sold | $3K |
Companies traded
- ALKS Alkermes plc.: other filings, last May 21, 2026
- COLL Collegium Pharmaceutical, Inc: 1 sale, last May 14, 2026
- EYPT EyePoint, Inc: 3 buys, 7 sales, last Jan 6, 2026
- AQST Aquestive Therapeutics, Inc: other filings, last Jun 15, 2021
- PSDV pSivida Corp: 1 buy, last Mar 19, 2018
- MNK Mallinckrodt plc: other filings, last Mar 16, 2016
- PDII PDI Inc: 5 buys, last Mar 5, 2015
- AUXL Auxilium Pharmaceuticals Inc: 2 sales, last Jan 29, 2015